Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1980 May;65(5):1111–1118. doi: 10.1172/JCI109764

Beta receptor occupancy. Assessment in the intact animal.

C J Homcy, H W Strauss, S Kopiwoda
PMCID: PMC371442  PMID: 6102571

Abstract

Organ uptake of 125I-hydroxybenzylpindolol, a potent beta adrenergic antagonist, was determined after intravenous administration. Pretreatment with the beta agonist, epinephrine, inhibited an almost identical fraction of 125I-hydroxybenzylpindolol binding as did the antagonist, propranolol. Specific beta receptor binding accounted for 50% of total uptake in the lung and demonstrated the following characteristics. The dose-response curve for propranolol inhibition of 125I-hydroxybenzylpindolol binding duplicated that reported for its physiologic action. Simultaneous serum propranolol levels as determined by a sensitive radioimmunoassay allowed an apparent dissociation rate constant approximately 7 nM to be obtained that correlated closely with the results reported from membrane binding studies. Alpha blockade had no effect and inhibition of 125I-hydroxybenzylpindolol binding by propranolol demonstrated stereospecificity. After chemical sympathectomy with reserpine or 6-OH dopamine, there was a 100% increase in receptor specific binding. Finally, a scintillation camera was employed to visually and quantitatively detect 125I-hydroxybenzylpindolol displacement from the lung during intravenous propranolol administration in the living animal. Reversal of binding was rapid and an in vivo inhibition curve was generated. Such a method provides the potential for longitudinally assessing beta receptor occupancy and apparent affinity directly in man.

Full text

PDF
1111

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adam K. R., Pullman L. G., Scholfield P. C. Isoprenaline- and exercise- induced tachycardia in the assessment of beta-adrenoceptor blocking drugs; a comparison between tolamolol, practolol and propranolol. Br J Pharmacol. 1973 Nov;49(3):560–563. doi: 10.1111/j.1476-5381.1973.tb17268.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aurbach G. D., Fedak S. A., Woodard C. J., Palmer J. S., Hauser D., Troxler F. Beta-adrenergic receptor: stereospecific interaction of iodinated beta-blocking agent with high affinity site. Science. 1974 Dec 27;186(4170):1223–1224. doi: 10.1126/science.186.4170.1223. [DOI] [PubMed] [Google Scholar]
  3. Axelrod J. Noradrenaline: fate and control of its biosynthesis. Science. 1971 Aug 13;173(3997):598–606. doi: 10.1126/science.173.3997.598. [DOI] [PubMed] [Google Scholar]
  4. Brown E. M., Fedak S. A., Woodard C. J., Aurbach G. D. Beta-Adrenergic receptor interactions. Direct comparison of receptor interaction and biological activity. J Biol Chem. 1976 Mar 10;251(5):1239–1246. [PubMed] [Google Scholar]
  5. Bylund D. B., Charness M. E., Snyder S. H. Beta adrenergic receptor labeling in intact animals with 125I-hydroxybenzylpindolol. J Pharmacol Exp Ther. 1977 Jun;201(3):644–653. [PubMed] [Google Scholar]
  6. Cuatrecasas P., Hollenberg M. D. Membrane receptors and hormone action. Adv Protein Chem. 1976;30:251–451. doi: 10.1016/s0065-3233(08)60481-7. [DOI] [PubMed] [Google Scholar]
  7. Cuatrecasas P., Tell G. P., Sica V., Parikh I., Chang K. J. Noradrenaline binding and the search for catecholamine receptors. Nature. 1974 Jan 11;247(5436):92–97. doi: 10.1038/247092a0. [DOI] [PubMed] [Google Scholar]
  8. Da Prada M., Zürcher Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range. Life Sci. 1976 Oct 15;19(8):1161–1174. doi: 10.1016/0024-3205(76)90251-4. [DOI] [PubMed] [Google Scholar]
  9. Glaubiger G., Lefkowitz R. J. Elevated beta-adrenergic receptor number after chronic propranolol treatment. Biochem Biophys Res Commun. 1977 Sep 23;78(2):720–725. doi: 10.1016/0006-291x(77)90238-8. [DOI] [PubMed] [Google Scholar]
  10. Hoebeke J., Vauquelin G., Strosberg A. D. The production and characterization of antibodies against beta-adrenergic antagonists. Biochem Pharmacol. 1978;27(11):1527–1532. doi: 10.1016/0006-2952(78)90480-x. [DOI] [PubMed] [Google Scholar]
  11. Kostrzewa R. M., Jacobowitz D. M. Pharmacological actions of 6-hydroxydopamine. Pharmacol Rev. 1974 Sep;26(3):199–288. [PubMed] [Google Scholar]
  12. Lefkowitz R. J., Williams L. T. Catecholamine binding to the beta-adrenergic receptor. Proc Natl Acad Sci U S A. 1977 Feb;74(2):515–519. doi: 10.1073/pnas.74.2.515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Levitzki A., Atlas D., Steer M. L. The binding characteristics and number of beta-adrenergic receptors on the turkey erythrocyte. Proc Natl Acad Sci U S A. 1974 Jul;71(7):2773–2776. doi: 10.1073/pnas.71.7.2773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lundborg P. Effect of reserpine on the subcellular distribution of 3H-alpha-methylnoradrenaline in the mouse heart. Br J Pharmacol. 1969 Jun;36(2):386–392. doi: 10.1111/j.1476-5381.1969.tb09514.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Maguire M. E., Wiklund R. A., Anderson H. J., Gilman A. G. Binding of (125I)iodohydroxybenzylpindolol to putative beta-adrenergic receptors of rat glioma cells and other cell clones. J Biol Chem. 1976 Mar 10;251(5):1221–1231. [PubMed] [Google Scholar]
  16. Roizen M. F., Moss J., Henry D. P., Weise V., Kopin I. J. Effect of general anesthetics on handling- and decapitation-induced increases in sympathoadrenal discharge. J Pharmacol Exp Ther. 1978 Jan;204(1):11–18. [PubMed] [Google Scholar]
  17. Spector S., Tarver J., Berkowitz B. Effects of drugs and physiological factors in the disposition of catecholamines in blood vessels. Pharmacol Rev. 1972 Jun;24(2):191–202. [PubMed] [Google Scholar]
  18. Sporn J. R., Harden T. K., Wolfe B. B., Molinoff P. B. beta-Adrenergic receptor involvement in 6-hydroxydopamine-induced supersensitivity in rat cerebral cortex. Science. 1976 Nov 5;194(4265):624–626. doi: 10.1126/science.10626. [DOI] [PubMed] [Google Scholar]
  19. U'Prichard D. C., Bylund D. B., Snyder S. H. (+/-)-[3H]Epinephrine and (-)[3H]dihydroalprenolol binding to beta1- and beta2-noradrenergic receptors in brain, heart, and lung membranes. J Biol Chem. 1978 Jul 25;253(14):5090–5102. [PubMed] [Google Scholar]
  20. Zeleznik A. J., Roth J. Demonstration of the insulin receptor in vivo in rabbits and its possible role as a reservoir for the plasma hormone. J Clin Invest. 1978 May;61(5):1363–1374. doi: 10.1172/JCI109054. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES